Claritas invests in drug adherence tool (Nashville Post)

Nashville-based health care private equity firm Claritas Health Ventures led emocha’s $6.2 million Series A funding round, the Nashville Post reports. CareFirst BlueCross BlueShield, Kapor Capital, PTX Capital, and TCP Venture Capital were additional backers, and Theresa Sexton, managing partner of Claritas, will join emocha’s board of directors. “The team at emocha is purposeful and passionate about challenged populations with chronic conditions, reducing the barriers to accessing high quality care, and leading the expansion of health equity,” Sexton said. “We are honored to partner with a team who shares the same drive to effect change as we do at Claritas Health Ventures.”